-
SGI-1027 DNA Methyltransferase Inhibitor Workflows
2026-08-27
SGI-1027 combines direct DNMT inhibition with a distinctive lysosomal cell-death phenotype, making it useful for integrated methylation, gene-reactivation, and renal cancer assays. This practical guide covers compound handling, concentration design, combination testing with everolimus, and interpretation of vacuolation, apoptosis, and pyroptosis.
-
N1-Methylpseudo-UTP for RNA Workflows
2026-08-26
N1-Methyl-Pseudouridine-5'-Triphosphate is a modified UTP analog for in vitro transcription of RNA with altered stability and translation behavior. N1-Methylpseudo-UTP supports mechanistic RNA studies and therapeutic mRNA development, but it is not itself a delivery system or a complete mRNA formulation.
-
Entecavir (BMS200475): HBV Research Workflows
2026-08-26
Entecavir (BMS200475) supports controlled HBV replication-inhibition studies across wild-type and lamivudine-resistant models. This practical guide covers assay setup, concentration design, orthogonal readouts, translational context, and troubleshooting for reproducible results.
-
Gut-to-Brain α-Synuclein Transfer via the Vagus
2026-08-25
A bioRxiv preprint presents evidence that intestinal epithelial and mucosal cells can provide a non-neuronal source of fibrillar α-synuclein capable of reaching vagal and hindbrain tissues. Using intestinal organoids, vagal neuron co-cultures, transgenic mice, RT-QuIC, and subdiaphragmatic vagotomy, the study supports a gut-to-brain pathway while leaving important questions about disease relevance and molecular transport unresolved.
-
Direct Mouse Genotyping Kit Plus Workflow
2026-08-25
Shorten mouse genotyping assay timelines by combining direct tissue lysis with high-fidelity PCR in a streamlined workflow. This guide shows how to apply the Direct Mouse Genotyping Kit Plus to colony screening, transgene detection, and gene knockout validation while preserving controls and troubleshooting discipline.
-
c-Myc Peptide: Immunoassay Workflow Guide
2026-08-24
Use the c-Myc tag peptide as a precise competition control for antibody specificity, epitope accessibility, and tagged-fusion-protein recovery. This practical guide connects that assay function with lessons from IRF3 selective-autophagy research without overstating the peptide as a cell-signaling modulator.
-
Polymyxin B Sulfate: Mechanism & Research Use
2026-08-24
Polymyxin B sulfate is a cationic polypeptide antibiotic that disrupts Gram-negative bacterial membranes and supports research on multidrug-resistant infections. Its strongest research value is as a membrane-active comparator in Gram-negative bacterial infection research, with separate applications in dendritic cell maturation assay and sepsis and bacteremia models.
-
RSL3 Glutathione Peroxidase 4 Inhibitor Workflows
2026-08-23
Build reproducible ferroptosis assays with RSL3, a selective GPX4 inhibitor suited to lipid-peroxidation, redox, and RAS-driven cancer studies. This guide connects practical dosing and rescue controls with PERK–SLC7A11 biology for sharper mechanism-of-action conclusions.
-
Sunitinib Workflows for RTK and RCC Research
2026-08-22
Build reproducible Sunitinib experiments around RTK inhibition, angiogenesis, cell-cycle control, and therapy resistance. This workflow also translates recent TRIB3–SLC7A11/GPX4 findings into practical assays for renal cell carcinoma models.
-
Erastin: Reading Ferroptosis Assays by Mechanism
2026-08-21
Erastin is a ferroptosis inducer that reveals how cystine deprivation, glutathione loss, iron, and lipid peroxidation converge in vulnerable tumor cells. This guide uses a recent breast cancer study to develop a more rigorous framework for interpreting oxidative cell-death assays.
-
Diuron: From Herbicide Mechanism to Renal Risk
2026-08-20
Diuron is more than a photosynthesis inhibitor: recent evidence positions it as a useful bridge between plant biology research, environmental toxicology, and mechanistic nephrotoxicity. This article translates JAK2/STAT1 findings into reproducible assay strategy and translational decision-making.
-
Anlotinib Hydrochloride in Angiogenesis Assays
2026-08-20
Anlotinib hydrochloride enables a practical, multi-pathway strategy for studying VEGFR2, PDGFRβ, and FGFR1-driven angiogenesis. This guide translates published endothelial, aortic-ring, and CAM findings into reproducible assay workflows, controls, and troubleshooting decisions for cancer research.
-
SCUBE3 Antibody Targeting: Signaling and Immunity
2026-08-19
The reference study identifies secreted SCUBE3 as a multifunctional driver of oncogenic signaling, therapy resistance, and tumor immune suppression. Its neutralizing antibody strategy links extracellular target inhibition with reduced tumor progression and restoration of antitumor immune activity in preclinical models.
-
Entecavir and BMS200475 in Chronic Hepatitis B
2026-08-19
This reference review positioned Entecavir, also known as BMS200475, as a clinically important advance in chronic hepatitis B by integrating biochemical, cell-based, animal, and trial evidence. Its central implication is that stronger HBV polymerase inhibition can improve viral suppression and liver-related outcomes while delaying resistance, although prolonged therapy remains necessary because intracellular cccDNA persists.
-
Live-Dead Cell Staining Kit for TNBC Assays
2026-08-18
Use the Live-Dead Cell Staining Kit I to convert treatment-induced changes in mammalian cell survival into a rapid, two-color fluorescence readout. Its Calcein AM/PI workflow is especially useful for screening gramine and separating endpoint viability from mechanistic ferroptosis measurements.